Methylenetetrahydrofolate reductase 677TT genotype might be associated with an increased lung cancer risk in Asians

Gene

Volumn 515, Issue 1, 2013, Pages 214-219

  Liu, Zheng Bing ^a   Wang, Li Ping ^a   Shu, Jun ^a   Jin, Cheng ^a   Lou, Zhi Xia ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; Meta analysis; Methylenetetrahydrofolate reductase; MTHFR

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALLELE; ARTICLE; ASIAN; CALCULATION; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG CARCINOMA; META ANALYSIS; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PUBLISHING; REFERENCE DATABASE; SYSTEMATIC REVIEW;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CODON; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84872278183     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.036     Document Type: Article

References (40)

1. Arslan S., Karadayi S., Yildirim M.E., Ozdemir O., Akkurt I. The association between methylene-tetrahydrofolate reductasegene polymorphism and lung cancer risk. Mol. Biol. Rep. 2011, 38:991-996.
2. Boccia S., et al. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett. 2009, 273:55-61.
3. Büchner F.L., et al. Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2010, 21(3):357-371.
4. Cheng Z., et al. Polymorphisms of the methylenetetrahydrofolate reductase C677T and risk of lung cancer. Chin. J. Tuberc. Respir. Dis. 2011, 34(1):57-58.
5. Crawford A., et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 2012, 501(2):89-103.
6. Cui L.H., et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med. Genet. 2011, 12:28.
7. Cui L.H., Yu Z., Zhang T.T., Shin M.H., Kim H.N., Choi J.S. Influence of polymorphisms in MTHFR 677 C→T, TYMS3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC. Pharmacogenomics 2011, 12(6):797-808.
8. Duthie S.J. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis. 2011, 34(1):101-109.
9. Egger M., Davey Smith G,., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
10. Gemignani F., et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 2007, 28(6):1287-1293.
11. Heijmans B.T., et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res. 2003, 63(6):1249-1253.
12. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
13. Hung R.J., et al. Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis 2007, 28(6):1334-1340.
14. Imanishi H., et al. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J. Hum. Genet. 2007, 52(2):166-171.
15. Jeng Y.L., et al. The methylenetetrahydrofolate reductase C677→T polymorphism and lung cancer risk in a Chinese population. Anticancer Res. 2003, 23:5149-5152.
16. Jin C., Zhang Y.H., Peng M.F., Li M.F., Ma L., Chen W.S. Study of the relationship between C677T, A1298C gene polymorphism of methylenetetrahydrofolate reductase and lung cancer. Chin. Clin. Oncol. 2007, 12(9):671-675.
17. Key T.J. Fruit and vegetables and cancer risk. Br. J. Cancer 2011, 104(1):6-11.
18. Khan N., Afaq F., Mukhtar H. Lifestyle as risk factor for cancer: evidence from human studies. Cancer Lett. 2010, 93(2):133-143.
19. Kim J.W., Park H.M., Choi Y.K., Chong S.Y., Oh D., Kim N.K. Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients. Oncol. Rep. 2011, 25(1):167-172.
20. Kiyohara C., Horiuchi T., Takayama K., Nakanishi Y. Methylenetetrahydro-folate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population. BMC Cancer 2011, 11:459.
21. La Merrill M., Torres-Sánchez L., Ruiz-Ramos R., López-Carrillo L., Cebrián M.E., Chen J. The association between first trimester micronutrient intake, MTHFR genotypes, and global DNA methylation in pregnant women. J. Matern. Fetal Neonatal Med. 2012, 25(2):133-137.
22. Lee M.S., Asomaning K., Su L., Wain J.C., Mark E.J., Christiani D.C. MTHFR polymorphisms, folate intake and carcinogen DNA adducts in the lung. Int. J. Cancer 2012, 131(5):1203-1209.
23. Liu H., et al. Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Lung Cancer 2008, 61(1):21-29.
24. Liu C.S., et al. Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics 2009, 6(6):325-329.
25. Liu F., He Y., Peng X., Wang W., Yang X. Association of the 8473T>C cyclooxygenase-2 (COX-2) gene polymorphism with lung cancer risk in Asians. Asian Pac. J. Cancer Prev. 2010, 11(5):1257-1262.
26. Mao R., Fan Y.H., Jin Y., Bai J., Fu S. Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis. J. Hum. Genet. 2008, 53:340-348.
27. Shen H.B., Spitz M.R., Wang L.E., Hong W.K., Wei Q. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 2001, 10:397-401.
28. Shen M., et al. Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer 2005, 49:299-309.
29. Shi Q.L., et al. Sex differences in risk of lung cancer associated with methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1477-1484.
30. Siemianowicz K., et al. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol. Rep. 2003, 10:1341-1344.
31. Suzuki T., et al. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case-control study. Carcinogenesis 2007, 28(8):1718-1725.
32. Vineis P., et al. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann. Oncol. 2007, 18(7):1230-1242.
33. Wang J., Chen J.P., Chen X., Wang B., Li K., Bi J. Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis. PLoS One 2011, 6(12):e28844.
34. Wani N.A., Hamid A., Kaur J. Folate status in various pathophysiological conditions. IUBMB Life 2008, 60(12):834-842.
35. Wei Q., et al. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol. Biomarkers Prev. 2003, 12(10):963-969.
36. Yang X.X., Li F.X., Yi J.P., Li X., Sun J.Z., Hu N.Y. Polymorphisms of the methylenetetrahydrofolate reductase C677T and risk of gastric cancer, colon cancer and lung cancer. Guangdong Med. J. 2010, 31(18):2375-2378.
37. Yao Q.F., Chen X., Xue J.R., Luo M., Xiao L., Yang C. Relationship of polymorphisms of MTHFR gene hypermethylation of tumor suppressor gene in lung cancer. Cancer Res. Prev. Treat. 2010, 37(5):531-534.
38. Zhang X.M., et al. Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of lung cancer. Acta Acad. Med. Sin. 2005, 27(6):700-703.
39. Zhang Y., et al. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: a meta-analysis. Respirology 2010, 15:643-650.
40. Zhang Y., et al. Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma. Mol. Biol. Rep. 2012, 39(5):6203-6211.